Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage Study
[ad_1] By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The…
[ad_1] By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The…
[ad_1] Most patients are unlikely to develop severe disease or die if they get the current variants of COVID-19 as immunity levels have climbed…
[ad_1] Pfizer Inc. PFE, -1.73% said Friday that the U.S. Food and Drug Administration has approved the first five-in-one vaccine designed to protect teenagers…
[ad_1] By Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD’s Lynparza cancer treatment had been approved in the U.S. for the treatment…
[ad_1] Loneliness is more than a bad feeling. It’s as deadly as smoking up to 15 cigarettes a day and is associated with a…
[ad_1] Moderna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect against Lyme disease, the tick-borne illness that causes a…
[ad_1] The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and…
[ad_1] … .wsj.com/articles/marijuana-cannabis-edibles-pot-cbd-health … Original Author Link click here to read complete story.. … Read More [ad_2] MMP News Author Source link
[ad_1] Many Americans dream of saving $1 million for retirement. Most fall far short of that. The typical family’s 401(k) and IRA-type accounts come…
[ad_1] If 80% of children ages 5 and older get their COVID booster shots by the end of 2022, it could prevent about 29…
[ad_1] A number of young children are being hospitalized because of respiratory syncytial virus, or RSV, and it’s happening at an unusual time of…